Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ophthalmic branch of the trigeminal nerve (CN V1) is the smallest and most superior of the three divisions of the trigeminal nerve. It is a purely sensory nerve responsible for transmitting sensory information from the upper face, scalp, and parts of the nasal cavity and sinuses to the brain. It has three main branches: the frontal, lacrimal, and nasociliary nerves, each providing sensation to specific regions. While not a therapeutic target itself, its function and integrity are crucial for maintaining sensory input and reflexes in the ophthalmic region, and it is implicated in conditions like trigeminal neuralgia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ophthalmic Branch of Trigeminal Nerve (CN V1).